Stem Cell Therapy for Heart Disease
心脏病干细胞治疗
Duration
2-4 weeks treatment; 6-12 months follow-up
Recovery
1-2 weeks post-procedure; cardiac improvement assessed at 3-6 months
Savings
~67% vs US
Average savings compared to US prices
Cardiac stem cell therapy for heart failure, ischemic cardiomyopathy, and post-myocardial infarction recovery using mesenchymal stem cells or cardiac progenitor cells. Chinese cardiovascular centers conduct clinical trials delivering stem cells via intracoronary, intramyocardial, or intravenous routes to promote cardiac repair. Programs combine cell therapy with optimized heart failure management.
Cardiac Assessment
Echocardiography, cardiac MRI, coronary angiography, and ejection fraction measurement
Duration: 2-3 daysCell Preparation
Autologous bone marrow harvest or allogeneic MSC selection and quality testing
Duration: 1-2 weeksCell Delivery
Intracoronary infusion during catheterization or intramyocardial injection via specialized catheter
Duration: 1-2 hoursCardiac Rehabilitation
Structured cardiac rehab program with serial echocardiography and functional capacity testing
Duration: 3-6 months- Potential to improve ejection fraction and reduce heart failure symptoms
- Chinese cardiovascular centers have extensive catheter-based delivery experience
- Combined with optimal medical and rehabilitative care
- May reduce hospitalizations for heart failure
- Arrhythmia risk during and after cell delivery
- Experimental nature with variable clinical outcomes
- Catheterization procedure carries inherent vascular risks
- Long-term benefit duration uncertain
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.